FDA officials outline need for oversight of AI in healthcare, biomedicine
Regulatory NewsJeff Craven
Artificial intelligence/machine learning (AI/ML)CDRHDigital health/SaMD/AIMedical DevicesNorth AmericaProduct LifecycleUS Food and Drug Administration (FDA)